Alcon News
Most Popular Alcon Story
Novartis pledges $39B for Alcon
In a bid to diversify its business away from traditional pharma, Novartis has bought a 25 percent stake in Alcon and is eyeing the purchase of another 52 percent in 2010. The Swiss drugmaker paid Read more...
Latest Headlines
- October 26, 2011
- September 28, 2011
- September 13, 2011
- September 2, 2011
- December 15, 2010
- October 25, 2010
- September 30, 2010
- September 8, 2010
- August 26, 2010
- August 16, 2010
- July 27, 2010
- July 20, 2010
- July 8, 2010
- June 28, 2010
- April 8, 2010
- February 12, 2010
- February 3, 2010
- January 20, 2010
- January 15, 2010
- January 12, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
